Details for Patent: 7,153,856

Title:	Cyclic protein tyrosine kinase inhibitors
Abstract:	Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
Inventor(s):	Barrish; Joel C. (Richboro, PA), Wityak; John (Carlsbad, CA), Das; Jagabandhu (Mercerville, NJ), Chen; Ping (Belle Mead, NJ), Norris; Derek J. (Pennington, NJ), Schieven; Gary (Lawrenceville, NJ)
Assignee:	Bristol-Myers Squibb Company (Princeton, NJ)
Filing Date:	May 26, 2005
Application Number:	11/138,942
Claims:	1. A method for the treatment of cancer, comprising the step of administering orally to a subject in need thereof an amount effective therefor of the compound ##STR00622## or salts thereof. 2. The method of claim 1, wherein the cancer is gastric cancer. 3. The method of claim 1, wherein the cancer is breast cancer. 4. The method of claim 1, wherein the cancer is colon carcinoma. 5. The method of claim 1, wherein the cancer is colorectal cancer. 6. The method of claim 1, wherein the cancer is lung cancer. 7. The method of claim 1, wherein the cancer is non small cell lung cancer. 8. The method of claim 1, wherein the cancer is ovarian cancer.